Alpha Tau to Present at Biotech Showcase and Participate in LifeSci Advisors Corporate Access Event During J.P. Morgan Healthcare Conference in San Francisco in January 2023

December 13, 2022

https://www.globenewswire.com/news-release/2022/12/13/2572650/0/en/Alpha-Tau-to-Present-at-Biotech-Showcase-and-Participate-in-LifeSci-Advisors-Corporate-Access-Event-During-J-P-Morgan-Healthcare-Conference-in-San-Francisco-in-January-2023.html

JERUSALEM, Dec. 13, 2022 (GLOBE NEWSWIRE) — Alpha Tau Medical Ltd. (Nasdaq:DRTS, DRTSW) (“Alpha Tau,” or the “Company”), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™, announced today that the Company plans to present at the Biotech Showcase™ and host institutional investor meetings at this event, as well as at the LifeSci Partners Corporate Access Event. Both in-person events are taking place in parallel with the 41st Annual J.P. Morgan Healthcare Conference which will be held January 9-12, 2023 in San Francisco, California.

Read more at globenewswire.com

Related news for (DRTS)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.